Lung Cancer Treatment in Abu Dhabi

Understanding Lung Cancer

Lung cancer is broadly divided into non-small cell lung cancer, the most common type, and small cell lung cancer. Symptoms can include a persistent cough, breathlessness, chest pain or coughing up blood, though early disease may cause no symptoms. Smoking is the leading risk factor, but lung cancer also occurs in people who have never smoked. Modern testing of the tumour's molecular features has made treatment far more personalised than in the past.

Diagnosis and Staging

Diagnosis usually involves imaging such as CT and PET-CT, followed by a biopsy to confirm the cancer type. Molecular and biomarker testing — for changes such as EGFR, ALK and PD-L1 — is essential because it determines whether targeted therapy or immunotherapy is suitable. Staging assesses the size of the tumour and whether it has spread to lymph nodes or other organs. Accurate staging and molecular profiling are the foundation of an effective plan.

Treatment Options in Abu Dhabi

Treatment depends on the cancer type, stage and molecular profile, and may include surgery, radiation, chemotherapy, targeted therapy or immunotherapy. Dr. Diab uses biomarker-guided targeted agents and immunotherapy where appropriate, following international ESMO protocols, and coordinates with thoracic surgery and radiation oncology at Mediclinic Abu Dhabi. For advanced disease, systemic therapies can control the cancer for extended periods while maintaining quality of life. Treatment intent is determined by stage and overall health.

What to Expect During Care

Care begins with a clear explanation of the cancer type, stage and test results, and a plan tailored to them. Side effects vary by treatment and are managed proactively, and breathing or symptom support is provided when needed. Many patients remain active during treatment. Regular follow-up with imaging monitors the response and guides any adjustments.

Frequently Asked Questions

Why is molecular testing important in lung cancer?

Molecular testing identifies specific changes in the tumour, such as EGFR or ALK, and measures markers like PD-L1. These results determine whether targeted therapy or immunotherapy is likely to work, allowing treatment to be personalised rather than one-size-fits-all.

Can lung cancer be treated if I have never smoked?

Yes. Lung cancer occurs in people who have never smoked, and these cancers often carry molecular changes that respond well to targeted therapy. Diagnosis and treatment follow the same careful, personalised approach regardless of smoking history.

How is advanced lung cancer treated in Abu Dhabi?

Advanced lung cancer is often treated with systemic therapy — chemotherapy, targeted therapy or immunotherapy — chosen according to the tumour's molecular profile. Treatment follows international protocols and is coordinated with other specialists at Mediclinic Abu Dhabi.